Just to add apart from generic flovent and ryaltris, the next 2 drugs will be envafolimab and winlevi. One more pmdi like flovent to be filed in fy 25 and launched in fy 26.
GPL is the only filer in flovent and market size of all doszge is 1.6 bn usd. Gpl as of now has filed for only 1 dosage, balance under process.